Hervé Lerat

2.4k total citations
37 papers, 1.9k citations indexed

About

Hervé Lerat is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Hervé Lerat has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 22 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Hervé Lerat's work include Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (17 papers) and Liver Disease Diagnosis and Treatment (16 papers). Hervé Lerat is often cited by papers focused on Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (17 papers) and Liver Disease Diagnosis and Treatment (16 papers). Hervé Lerat collaborates with scholars based in France, United States and United Kingdom. Hervé Lerat's co-authors include Martin R. Higgs, Jean–Michel Pawlotsky, Stanley M. Lemon, Geneviève Inchauspé, C. Trépo, Françoise Berby, Mary‐Anne Trabaud, Masao Honda, Steven A. Weinman and Michiari Okuda and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Hervé Lerat

37 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hervé Lerat France 23 1.2k 1.1k 416 203 135 37 1.9k
Yoshihide Fukuda Japan 24 853 0.7× 690 0.6× 327 0.8× 149 0.7× 163 1.2× 87 1.7k
Joachim Lupberger France 19 582 0.5× 626 0.6× 484 1.2× 165 0.8× 136 1.0× 37 1.4k
Vito L. Burgio Italy 24 355 0.3× 589 0.5× 444 1.1× 698 3.4× 426 3.2× 45 2.0k
Kazumasa Hiroishi Japan 20 583 0.5× 453 0.4× 250 0.6× 750 3.7× 299 2.2× 44 1.5k
Yasuhiro Nakayama Japan 19 234 0.2× 291 0.3× 382 0.9× 276 1.4× 166 1.2× 60 1.0k
Andrew E. Greenstein United States 17 225 0.2× 295 0.3× 497 1.2× 167 0.8× 181 1.3× 37 1.1k
Silke Hegenbarth Germany 18 553 0.5× 507 0.5× 315 0.8× 1.1k 5.2× 324 2.4× 20 1.9k
Jared Klarquist United States 24 513 0.4× 434 0.4× 314 0.8× 1.1k 5.4× 307 2.3× 40 1.8k
L Braun United States 16 530 0.4× 456 0.4× 417 1.0× 110 0.5× 285 2.1× 21 1.2k
Toshiaki Mizuochi Japan 27 232 0.2× 338 0.3× 334 0.8× 1.3k 6.2× 201 1.5× 72 2.0k

Countries citing papers authored by Hervé Lerat

Since Specialization
Citations

This map shows the geographic impact of Hervé Lerat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Lerat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Lerat more than expected).

Fields of papers citing papers by Hervé Lerat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Lerat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Lerat. The network helps show where Hervé Lerat may publish in the future.

Co-authorship network of co-authors of Hervé Lerat

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Lerat. A scholar is included among the top collaborators of Hervé Lerat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Lerat. Hervé Lerat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurma, Keerthi, Julien Ghelfi, Carole Fournier, et al.. (2022). Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma. Cells. 11(13). 2051–2051. 8 indexed citations
2.
3.
Roth, Gaël S., et al.. (2021). Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. International Journal of Molecular Sciences. 22(4). 1794–1794. 36 indexed citations
4.
Herzog, Katharina, Simonetta Bandiera, Catherine Fauvelle, et al.. (2019). Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity. Gut. 69(2). 380–392. 28 indexed citations
5.
Lerat, Hervé, Flora Donati, Martin R. Higgs, et al.. (2017). Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice. Journal of Biological Chemistry. 292(31). 12860–12873. 19 indexed citations
6.
Chouteau, Philippe, Nicole Defer, Julien Caldéraro, et al.. (2012). Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent. Journal of Hepatology. 57(3). 499–507. 16 indexed citations
7.
Lerat, Hervé, Martin R. Higgs, & Jean–Michel Pawlotsky. (2011). Animal models in the study of hepatitis C virus-associated liver pathologies. Expert Review of Gastroenterology & Hepatology. 5(3). 341–352. 22 indexed citations
8.
Higgs, Martin R., Hervé Lerat, & Jean–Michel Pawlotsky. (2010). Downregulation of Gadd45β Expression by Hepatitis C Virus Leads to Defective Cell Cycle Arrest. Cancer Research. 70(12). 4901–4911. 53 indexed citations
9.
Díaz‐Valdés, Nancy, Lorea Manterola, Virginia Belsúe, et al.. (2010). Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10. Hepatology. 53(1). 23–31. 23 indexed citations
10.
Pawlotsky, Jean–Michel, Laurence Cocquerel, David Durantel, et al.. (2009). HCV Research 20 Years After Discovery: A Summary of the 16th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology. 138(1). 6–12.e2. 5 indexed citations
11.
Zucman‐Rossi, Jessica, Bruno Clément, Hervé Lerat, et al.. (2009). Recherche fondamentale et translationnelle sur le carcinome hépatocellulaire en 2008 : avancées récentes et perspectives. Bulletin du Cancer. 96(1). 45–50. 1 indexed citations
12.
Lerat, Hervé, Hélène L. Kammoun, Isabelle Hainault, et al.. (2009). Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice. Journal of Biological Chemistry. 284(48). 33466–33474. 79 indexed citations
13.
14.
Keasler, Victor V., Hervé Lerat, Charles R. Madden, et al.. (2006). Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology. 347(2). 466–475. 26 indexed citations
15.
Disson, Olivier, D. Haouzi, Solange Desagher, et al.. (2004). Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology. 126(3). 859–872. 53 indexed citations
16.
Erdtmann, Lars, Nathalie Franck, Hervé Lerat, et al.. (2003). The Hepatitis C Virus NS2 Protein Is an Inhibitor of CIDE-B-induced Apoptosis. Journal of Biological Chemistry. 278(20). 18256–18264. 95 indexed citations
17.
Lerat, Hervé, Masao Honda, Michael R. Beard, et al.. (2002). Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology. 122(2). 352–365. 377 indexed citations
18.
Disson, Olivier, Michael Hahne, Urszula Hibner, & Hervé Lerat. (2002). Hepatocytes Transgenic for the Full Hepatitis C Virus Open Reading Frame Are Resistant to Fas‐Induced Cell Death. Annals of the New York Academy of Sciences. 973(1). 214–217. 1 indexed citations
19.
Lerat, Hervé & Geneviève Inchauspé. (1997). Tropisme extrahépatique du virus de l'hépatite C. Virologie. 1(4). 291–300. 3 indexed citations
20.
Lerat, Hervé, Françoise Berby, Mary‐Anne Trabaud, et al.. (1996). Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells.. Journal of Clinical Investigation. 97(3). 845–851. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihide Fukuda Breakdown of academic impact, for papers by Joachim Lupberger Breakdown of academic impact, for papers by Vito L. Burgio Breakdown of academic impact, for papers by Kazumasa Hiroishi Breakdown of academic impact, for papers by Yasuhiro Nakayama Breakdown of academic impact, for papers by Andrew E. Greenstein Breakdown of academic impact, for papers by Silke Hegenbarth Breakdown of academic impact, for papers by Jared Klarquist Breakdown of academic impact, for papers by L Braun Breakdown of academic impact, for papers by Toshiaki Mizuochi
Rankless by CCL
2026